Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barrie Peck

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Cancer Research : MCR|March 3, 2026
Expression of Concern: FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer CellsJimmy M-M Kwok, Barrie Peck, Lara J Monteiro, et al.
Oncogene|June 7, 2018
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinomaHeike Miess, Beatrice Dankworth, Arvin M Gouw, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Molecular Cancer Therapeutics|April 8, 2010
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Cancer & Metabolism|November 28, 2013
Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growthBeatrice Griffiths, Caroline A Lewis, Karim Bensaad, et al.
The Journal of Pathology|August 12, 2016
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelSarah L Maguire, Barrie Peck, Patty T Wai, et al.
Molecular Cancer Therapeutics|March 12, 2009
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancerUrsula B McGovern, Richard E Francis, Barrie Peck, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: Gefitinib (Iressa) Represses FOXM1 Expression via FOXO3a in Breast CancerUrsula B McGovern, Richard E Francis, Barrie Peck, et al.
Molecular Cancer Therapeutics|November 28, 2018
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism ModifiersDylan T Jones, Alessandro Valli, Syed Haider, et al.
Cell Reports|September 30, 2014
Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenationKarim Bensaad, Elena Favaro, Caroline A Lewis, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Cancer Research : MCR|March 3, 2026
Expression of Concern: FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer CellsJimmy M-M Kwok, Barrie Peck, Lara J Monteiro, et al.
Oncogene|June 7, 2018
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinomaHeike Miess, Beatrice Dankworth, Arvin M Gouw, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Molecular Cancer Therapeutics|April 8, 2010
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Cancer & Metabolism|November 28, 2013
Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growthBeatrice Griffiths, Caroline A Lewis, Karim Bensaad, et al.
The Journal of Pathology|August 12, 2016
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelSarah L Maguire, Barrie Peck, Patty T Wai, et al.
Molecular Cancer Therapeutics|March 12, 2009
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancerUrsula B McGovern, Richard E Francis, Barrie Peck, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: Gefitinib (Iressa) Represses FOXM1 Expression via FOXO3a in Breast CancerUrsula B McGovern, Richard E Francis, Barrie Peck, et al.
Molecular Cancer Therapeutics|November 28, 2018
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism ModifiersDylan T Jones, Alessandro Valli, Syed Haider, et al.
Cell Reports|September 30, 2014
Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenationKarim Bensaad, Elena Favaro, Caroline A Lewis, et al.
Pageof 3